Prednisone Patent Expiration

1. Rayos patent expiration

RAYOS's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6677326 HORIZON Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
Mar, 2020

(4 years ago)

US6488960 HORIZON Corticosteroid formulation
Mar, 2020

(4 years ago)

US9186332 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(2 months ago)

US9040085 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(2 months ago)

US8394407 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(2 months ago)

US8309124 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(2 months ago)

US9504699 HORIZON Delayed-release glucocorticoid treatment of rheumatoid disease
Aug, 2027

(3 years from now)

US8168218 HORIZON Delayed release tablet with defined core geometry
Jan, 2028

(3 years from now)




Drug Exclusivity Drug Exclusivity Expiration
M(M-128) Jul 26, 2015

Market Authorisation Date: 26 July, 2012

Treatment: Treatment of pulmonary, gastrointestinal and/or rheumatological diseases or conditions by use of delayed release formulations of 1mg or 2mg prednisone; Treatment of rheumatoid arthritis by delayed rel...

Dosage: TABLET, DELAYED RELEASE

How can I launch a generic of RAYOS before it's drug patent expiration?
More Information on Dosage

RAYOS family patents

Family Patents